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Table. Parsimonious model with predictor variables and estimated odds-ratio
predicting BARC 1 or greater bleeding events.
Effect*
Odds
Ratio
Lower
Conﬁdence
Limit
Upper
Conﬁdence
Limit
Caucasian Race 2.85 2.14 3.79
Diabetes Mellitus 0.55 0.44 0.67
Female Sex 1.75 1.37 2.23
Warfarin therapy on admission 2.03 1.26 3.27
Use of Drug Eluting Stent 1.52 1.20 1.91
History of Chronic Lung Disease 1.66 1.20 2.28
Urgent PCI vs. Elective/Planned
PCI
0.77 0.62 0.94
Emergent PCI vs. Elective/Planned
PCI
1.02 0.56 1.87
Platelets (per 50,000 units/dl) 0.90 0.83 0.96
Body Mass Index (Kg/m2) per 5
unit increment
0.92 0.85 1.00
Current Smoker 0.79 0.61 1.02
Age (per 10 year increment) 0.91 0.83 1.01
Hemoglobin 13 to <15 vs.
Hemoglobin  15 (gm/dl)
1.19 0.94 1.51
Hemoglobin <13 vs. Hemoglobin
 15 (gm/dl)
1.13 0.86 1.50
STEMI 0.59 0.29 1.17
History of Peripheral Arterial
Disease
1.25 0.87 1.79
* We used Harrell’s backward selection strategy to select a parsimonious set of variables for
the ﬁnal model from a larger set of covariates selected a-priori. In this selection strategy,
variables with the smallest contribution to the model (by F-value) are sequentially eliminated
until further variable elimination leads to a greater than 5% loss in model prediction, as
compared with the initial fully adjusted model.
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Background: The use of drug-eluting stents necessitates prolonged dual antiplatelet
therapy after PCI, which increases patents’ risk for bleeding complications. However,
there are no models to predict long-term bleeding events in patients undergoing PCI.
Methods: A total of 3,128 PCI procedures in the multicenter PRISM study were
analyzed. Patient reported bleeding events were categorized by Bleeding Academic
Research Consortium (BARC) deﬁnitions; 0 (no-bleed), 1 (bleeding/bruising not
requiring treatment), 2 (bleeding that is actionable), or 3 (needing hospitalization/
transfusion). We used logistic regression to develop a model predicting BARC  1
bleeding. Discrimination and calibration were used to evaluate model performance. A
sensitivity analysis was performed for BARC 1 or greater bleeding events excluding
easy bruising.
Results: No bleeding and BARC 1, 2 and 3 bleeding were observed in 574
(18.4%); 2382 (76.2%); 114 (3.6%) and, 58 (1.8%) patients, respectively, at one
year. Compared with patients with no-bleeding, patients with BARC  1
bleeding were more often female (30 vs. 23%), and Caucasian (94 vs. 83%), and
had a higher incidence of DES implantation (83 vs. 76%) and warfarin therapy
(7.4 vs. 3.9%) and less diabetes (31 vs. 45%; p-value < 0.01 for all compari-
sons). The model discriminated well (c-statistic of 0.672), as did a more parsi-
monious model (table; c-statistic ¼ 0.669). There was excellent calibration
(Hosmer-Lemeshow; p¼0.915), indicating good ﬁt. Only easy bruising was
observed in 602 (19.2%) patients, and sensitivity analyses excluding easy
bruising from BARC  1 bleeding had slightly lower discrimination (c-statistic
0.621).
Covariates eligible for inclusion in the model: Age, sex, race, high school educa-
tion, no insurance, current smoker, history of peripheral arterial disease, history of
diabetes mellitus, history of chronic kidney disease, history of myocardial infarction,
prior PCI, history of heart failure, history of prior stroke, history of hypertension,
history of dyslipidemia,history of chronic lung disease, Chronic Kidney Disease (GFR
60, 30-59, <30 and dialysis), hemoglobin, platelet count, PCI indication (urgent,
emergent or elective/planned), STEMI vs. other indication presentation for PCI, use of
drug eluting stent, warfarin on admission, access site (radial, femoral or brachial) and
cardiac arrest on arrival.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/AngioplasConclusions: A large proportion of patients report bleeding complications after
PCI, and these can be predicted by pre-procedural characteristics. Estimates of
bleeding risk may help support shared decision-making with respect to stent
selection during PCI.
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Background: Complete revascularization (CR) is considered as a goal for percuta-
neous coronary intervention (PCI). Previous studies have proved that achieving CR is
beneﬁcial compared to incomplete CR. However there has been no research about the
long term outcome within CR patients.
Methods: From patients enrolled in the Efﬁcacy of Xience/Promus versus Cypher in
rEducing Late Loss after stENTing (EXCELLENT) registry, the SYNTAX score was
checked before and after PCI. The primary clinical outcome was 3-year patient-ori-
ented composite endpoint (POCE), which was a composite of all cause death, any
myocardial infarction, and any revascularization. Secondary outcomes were the in-
dividual components of 3-year POCE and 3-year target lesion failure (TLF). For
calculation of the clinical SS, the SS was multiplied with the value of the ‘Age,
Creatinine, and Ejection Fraction’ score.
Results: Among 5,102 patients from the EXCELLENT registry, 2,112 patients
achieved CR by PCI. 3-year POCE was less common in CR patients (10.0% vs.
16.9%, p< 0.001) and CR was an independent predictor of adverse outcomes
(Hazard ratio (HR) 1.326, 95% Conﬁdence Interval (CI) 1.108-1.587, p¼0.002).
Patients who achieved CR were divided into 3 groups, according to the pre-PCI
SYNTAX score (SS); 1low-SS< 6: 771 patients, 6mid-SS< 10: 692 patients, and
high-SS10: 649 patients. 3-year POCE increased signiﬁcantly along with increasing
baseline SS tertiles (7.5% vs. 8.4% vs. 14.8%, p< 0.001) and secondary outcomes
also showed similar tendency. Multivariate analysis showed that baseline SS was an
independent predictor of 3-year POCE (HR 1.032, 95% CI 1.011-1.053, p¼0.003 perty Overview and Outcomes B29
Number of patients 23
Number of lesions treated 43
Number of stents 45
Stent diameter (mm) 2.90.6
Stent length (mm) 17.16.2
Length of follow-up (days) 709348
MI/mortality on follow-up 0
Binary restenosis 5.57% (3/45)
Target vessel revascularization 16.7% (5/30)
Target lesion revascularization 6.98% (3/43)
Quantitative coronary angiography (QCA)
Pre-
procedure
Post-
procedure
Follow-up p-value
RVD (mm) 2.660.79 2.890.75 2.820.71 <0.05
Diameter stenosis (%) 74.915.9 8.083.63 11.16.67 <0.0001
MLD (mm) 0.650.34 2.650.67 2.490.63 <0.0001
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comSS point). The clinical SS was superior to baseline SS in predicting 3-year POCE
(AUC: 0.595 vs. 0.649, p¼0.008). In subgroup analysis, baseline SS was a predictor
for POCE only in multi-vessel diseases (HR 1.027, 95% CI 1.001-1.054, p¼0.042
per SS point).
Conclusions: CR is an independent predictor of 3-year POCE in patients receiving
PCI. However, even after CR is achieved to make the post-PCI SS zero, baseline SS
still has predictive value of 3-year clinical outcomes. Moreover, the predictivity is was
superior in multi-vessel diseases.
TCT-99
Clinical outcome, safety, patient satisfaction and costs savings of same-day
discharge for elective percutaneous coronary intervention
Beatriz Samaniego1, Jose Miguel Vegas1, Iñigo Lozano1, Juan Rondan Murillo1,
Hernandez Ernesto1, Victor Leon1
1Hospital de Cabueñes, Gijon, Spain
Background: Overnight admission after elective percutaneous coronary inter-
vention(PCI)still constitutes the standard approach in most interventional cardiology
centers. Advances in PCI techniques have reduced the incidence of post-procedure
complications. The objective of this prospective,single-center study was to assess
the feasibility, safety, acceptance and cost savings of same-day discharge PCI
program.
Methods: Eligibility for outpatient management was assessed in 95 consecutive
patients undergoing elective PCI from January 2013 to April 2014. Exclusion
criteria for early discharge were age>80, severe renal failure, LVEF< 35%,
distance from home to hospital >40 km, high risk coronary anatomy or com-
plications during procedure. Major adverse cardiac events,vascular complications
and readmission were assessed 1-day and 1-month post discharge. Troponin,
EKG and a satisfaction survey were collected within 24 hours post PCI sched-
uled visit.
Results: 39 patients (41%) were cleared for discharge. The remaining 56(59%)
stayed overnight for high risk coronary anatomy (n¼51, 91%), chest discomfort
(n¼4, 7%) or treatment with abciximab (n¼1, 2%). Mean post PCI hospital stay
was 8:48 h for outpatients group. None patient was readmitted. There were no
vascular complications. EKG collected in 24-hours-visit show non-speciﬁc changes
in 3 patients. 7 patients hd troponin elevation without angina or EKG ischemic
changes. After one-month follow up only 2 patients had adverse events: a bare
metal stent thrombosis (day 7 after procedure) and 1 gastrointestinal bleeding with
diagnosis of colonic cancer. These complications could not have been avoided with
overnight hospital admission. Early discharge was well valuated with mean patient
satisfaction score of 4,50,5 (1 to 5). 87% of outpatients would choose early
discharge in case of new PCI. Using diagnosis-related groups costs established
in our institution, there were lower cost in the early discharge group, with a mean
cost of 2.480 vs 2.880 Euro in the routine care group. Mean of expense savings
was 16%.
Conclusions: In our experience same-day discharge after elective PCI is feasible, safe
and well accepted in selected patients and results in a cost-saving strategy.
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Background: Transplant coronary artery disease (TCAD) is a major cause of mor-
tality in patients after orthotopic heart transplantation (OHT). Use of systemic ever-
olimus has been shown to help prevent allograft vasculopathy in OHT patients. This
study examined the clinical and angiographic efﬁcacy, safety, and clinical outcomes of
Xience V, a second-generation everolimus-eluting stent (EES), in patients with
TCAD.
Methods: Post-OHT patients with hemodynamically signiﬁcant CAD (left main
50% or angiographic diameter stenosis 70%) underwent percutaneous coronary
intervention (PCI) with EES. We examined procedural success rates, one- and two-
year mortality, and myocardial infarction rates. Primary end-point was target lesion
revascularization (TLR). Surveillance angiography was performed at 1 year and
subsequently as clinically indicated on a per-patient basis. Quantitative coronary
angiography (QCA) was used for stenosis analysis at baseline, post-procedure, and
follow-up.
Results: 23 patients were included in the study. PCI was performed in 43 lesions
with 45 denovo EES placed. 2 stents were placed into the left main, 20 in the left
anterior descending, 12 in the right coronary, and 9 in the left circumﬂex artery. The
average stent length was 17.16.2mm and the average stent diameter was
2.90.6mm. Procedural success rate was 100%. All patients received angiographic
follow-up, with average length of follow-up 709348 days. There were no peri-
procedural, 1-year, or 2-year deaths/ MIs. Binary restenosis events were 5.57%
(3/45). Target vessel revascularization (TVR) rate was 16.7% (5/30), and TLR rate
was 6.98% (3/43).B30 JACC Vol 64/11/Suppl B j SeptembConclusions: Long term follow-up of EES placements in OHT patients with TCAD
are associated with a very low incidence of target lesion revascularization. Continued
follow-up and further studies are indicated to determine whether EES can positively
affect the progression and overall outcome of TCAD.
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Background: Routine control angiography is a valuable tool with high-sensitivity in
detecting restenosis after coronary stenting. However, the prognostic role of restenosis
is still controversial. We investigated the impact of restenosis on 4-year mortality in
patients undergoing routine control angiography after coronary stenting.
Methods: All patients undergoing successful implantation of coronary stents for de
novo lesions from 1998 to 2009 and routine control angiography after 6 to 8 months at
2 centres in Munich, Germany were studied. Restenosis was deﬁned as diameter
stenosis50% in the in-segment area at follow-up angiography. The primary outcome
was 4-year mortality.
Results: This study included 10,004 patients with 15,004 treated lesions. Restenosis
was detected in 2,643 (26.4%) patients. Overall, there were 702 deaths during
follow-up. Of these, 218 deaths occurred among patients with restenosis and 484
deaths occurred among patients without restenosis (unadjusted hazard ratio - HR
1.19; [95% conﬁdence interval - CI 1.02 to 1.40]; p¼ 0.03). The Cox proportional
hazards model adjusting for other variables identiﬁed restenosis as an independent
correlate of 4-year mortality (HR 1.23; [95% CI 1.03 to 1.46]; p¼ 0.02). Other
independent correlates of 4-year mortality were age (for each 10-year increase, HR
2.34; [95% CI 2.12 to 2.60]; p< 0.001), diabetes mellitus (HR 1.68; [95% CI 1.41 to
1.99]; p< 0.001), current smoking habit (HR 1.39; [95% CI 1.09 to 1.76]; p¼ 0.01)
and left ventricular ejection fraction (for each 5% decrease, HR 1.39; [95% CI 1.31
to 1.48]; p< 0.001).
Conclusions: In this large cohort of patients with routine control angiography after
coronary stenting the presence of restenosis was a strong independent predictor of
4-year mortality.
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Background: Chest pain and angina have negative impact on patient quality of life
and medical costs. Real-world data describing the incidence of recurrent angina, chest
pain and their impact on re-intervention following percutaneous coronary intervention
(PCI) are scarce. We sought to describe the incidence and impact of post-PCI angina
and chest pain using real-world data from a large claims database.er 13–17, 2014 j TCT Abstracts/Angioplasty Overview and Outcomes
